The controlled use of vasodilator drugs in the management of hypovolaemia complicated by diminished cardiac function.
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use; D001803:Blood Transfusion; D001810:Blood Volume; D001831:Body Temperature; D002496:Central Venous Pressure; D002746:Chlorpromazine / Q000627:therapeutic use*; D005260:Female; D006350:Heart Valve Prosthesis; D006402:Hematologic Diseases / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D012770:Shock, Cardiogenic / Q000150:complications* / Q000188:drug therapy; D012881:Skin Temperature; D014665:Vasodilator Agents / Q000627:therapeutic use; D014690:Venous Pressure
D000317:Adrenergic alpha-Antagonists; D014665:Vasodilator Agents; D002746:Chlorpromazine